Metabolism of 2-methyladenosine in Mycobacterium tuberculosis (Q44945057)

7 December 2017

title

Metabolism of 2-methyladenosine in Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

7 December 2017

main subject

0 references

2-Methyladenosine

1 reference

ChEBI release 2020-05-28

William B Parker

1

1 reference

7 December 2017

Esther W Barrow

2

1 reference

7 December 2017

Paula W Allan

3

1 reference

7 December 2017

Sue C Shaddix

4

1 reference

7 December 2017

Mary C Long

5

1 reference

7 December 2017

William W Barrow

6

1 reference

7 December 2017

Namita Bansal

7

1 reference

7 December 2017

Joseph A Maddry

8

1 reference

7 December 2017

publication date

1 January 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

84

1 reference

7 December 2017

issue

5

1 reference

7 December 2017

page(s)

327-336

1 reference

Antimycobacterial activity of 2-methyl-adenosine

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Purine nucleoside phosphorylase from Mycobacterium tuberculosis. Analysis of inhibition by a transition-state analogue and dissection by parts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

7 January 2021

New fronts in an old war

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

The metabolism of 2-methyladenosine in Mycobacterium smegmatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Identification and Characterization of a Unique Adenosine Kinase from Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Search for new drugs for treatment of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Structural analyses reveal two distinct families of nucleoside phosphorylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Structures of purine nucleoside phosphorylase from Mycobacterium tuberculosis in complexes with immucillin-H and its pieces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.02.004

10.1016/J.TUBE.2004.02.004

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference